Journal article · 2026 · Open access
Confirmed Multiple Drug Hypersensitivity Syndrome is Uncommon, and its Culprit Drug Spectrum Reflects Patterns of Drug Exposure
Clinical Pharmacology & Therapeutics · Published 10 November 2026 · DOI 10.1002/cpt.70563
In brief
“Confirmed Multiple Drug Hypersensitivity Syndrome is Uncommon, and its Culprit Drug Spectrum Reflects Patterns of Drug Exposure” is a 2026 journal article by Da Woon Sim and 2 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 0 citations as of 18 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Clinical Pharmacology & Therapeutics.
- Citations
- 0
- References
- 31
- Authors
- 3
Abstract
Multiple drug hypersensitivity syndrome (MDHS) is defined as confirmed hypersensitivity to two or more chemically and pharmacologically unrelated drug entities. Few studies have characterized MDHS with systematic diagnostic confirmation. We aimed to determine the frequency, culprit drug patterns, and diagnostic findings of confirmed MDHS. We retrospectively reviewed patients evaluated for suspected drug hypersensitivity at a Korean tertiary allergy center from March 2017 to April 2026. MDHS required confirmed hypersensitivity to at least two unrelated drug entities by skin testing, serum-specific IgE, or provocation testing; cross-reactive reactions were not counted separately. Among 6684 evaluated patients, 3007 underwent diagnostic testing, and 1380 were tested for multiple suspected drugs. MDHS was confirmed in 94 patients (1.4%, 3.1%, and 6.8%, respectively). Anaphylaxis was the most common manifestation (38.3%). Most patients (84.0%) reacted to two entities, whereas 12.8% and 3.2% reacted to three and four entities, respectively. Leading culprits were β-lactams (n = 34), nonsteroidal anti-inflammatory drugs (NSAIDs)/acetaminophen (n = 34), antituberculosis agents (n = 27), and histamine-2 receptor antagonists (n = 19). Recurrent combinations involved first-line antituberculosis agents and NSAIDs plus ranitidine. Of 114 entities confirmed by drug provocation, 38 had negative preceding skin tests. Delayed-reading intradermal testing was more frequently positive in drug reaction with eosinophilia and systemic symptoms (DRESS) than in maculopapular exanthema (MPE) (53.3% vs. 0.0%, P = 0.008). Confirmed MDHS was uncommon despite suspected hypersensitivity to multiple drugs. The clinical presentation resembled European cohorts, whereas the culprit spectrum reflected regional prescribing patterns. Systematically evaluating each suspected entity may preserve future treatment options.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Sim, D. W., Yu, J. E., & Koh, Y. (2026). Confirmed Multiple Drug Hypersensitivity Syndrome is Uncommon, and its Culprit Drug Spectrum Reflects Patterns of Drug Exposure. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70563
MLA 9
Sim, Da Woon, et al. “Confirmed Multiple Drug Hypersensitivity Syndrome is Uncommon, and its Culprit Drug Spectrum Reflects Patterns of Drug Exposure.” Clinical Pharmacology & Therapeutics, 2026. https://doi.org/10.1002/cpt.70563.
Chicago
Sim, Da Woon, Ji Eun Yu, and Young‐Il Koh. 2026. “Confirmed Multiple Drug Hypersensitivity Syndrome is Uncommon, and its Culprit Drug Spectrum Reflects Patterns of Drug Exposure.” Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70563.
Harvard
Sim, D. W., Yu, J. E. and Koh, Y. (2026) ‘Confirmed Multiple Drug Hypersensitivity Syndrome is Uncommon, and its Culprit Drug Spectrum Reflects Patterns of Drug Exposure’, Clinical Pharmacology & Therapeutics. doi:10.1002/cpt.70563.
IEEE
D. W. Sim, J. E. Yu, and Y. Koh, “Confirmed Multiple Drug Hypersensitivity Syndrome is Uncommon, and its Culprit Drug Spectrum Reflects Patterns of Drug Exposure,” Clinical Pharmacology & Therapeutics, 2026, doi: 10.1002/cpt.70563.
BibTeX
@article{sim2026confirmed,
title = {{Confirmed Multiple Drug Hypersensitivity Syndrome is Uncommon, and its Culprit Drug Spectrum Reflects Patterns of Drug Exposure}},
author = {Sim, Da Woon and Yu, Ji Eun and Koh, Young‐Il},
journal = {Clinical Pharmacology \& Therapeutics},
year = {2026},
doi = {10.1002/cpt.70563},
url = {https://doi.org/10.1002/cpt.70563}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- drug hypersensitivity
- beta-lactam antibiotics
- nonsteroidal anti-inflammatory drugs
- antitubercular agents
- H2 receptor antagonists
- ranitidine
- clothing
- maculopapular exanthema
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Sim, D. W., Yu, J. E., & Koh, Y. (2026). Confirmed Multiple Drug Hypersensitivity Syndrome is Uncommon, and its Culprit Drug Spectrum Reflects Patterns of Drug Exposure. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70563
How many times has this paper been cited?
0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.
Who wrote this paper?
Da Woon Sim, Ji Eun Yu, Young‐Il Koh.
What is the DOI of this paper?
10.1002/cpt.70563, permanently at https://doi.org/10.1002/cpt.70563. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.